BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3625703)

  • 1. Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents.
    Leung CS; Rowlands MG; Jarman M; Foster AB; Griggs LJ; Wilman DE
    J Med Chem; 1987 Sep; 30(9):1550-4. PubMed ID: 3625703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analogues of aminoglutethimide: selective inhibition of aromatase.
    Foster AB; Jarman M; Leung CS; Rowlands MG; Taylor GN; Plevey RG; Sampson P
    J Med Chem; 1985 Feb; 28(2):200-4. PubMed ID: 3968684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biochemical evaluation of analogues of aminoglutethimide based on phenylpyrrolidine-2,5-dione.
    Daly MJ; Jones GW; Nicholls PJ; Smith HJ; Rowlands MG; Bunnett MA
    J Med Chem; 1986 Apr; 29(4):520-3. PubMed ID: 3754286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational analysis of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione (rogletimide) and discovery of potent 5-alkyl derivatives.
    McCague R; Rowlands MG
    J Med Chem; 1992 Oct; 35(20):3699-704. PubMed ID: 1433182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analogues of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage.
    Foster AB; Jarman M; Leung CS; Rowlands MG; Taylor GN
    J Med Chem; 1983 Jan; 26(1):50-4. PubMed ID: 6827528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase.
    Seago A; Baker MH; Houghton J; Jarman M; Leung CS; Rowlands MG
    Biochem Pharmacol; 1988 Jun; 37(11):2167-72. PubMed ID: 3377817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogues of aminoglutethimide based on 1-phenyl-3-azabicyclo[3.1.0]hexane-2,4-dione: selective inhibition of aromatase activity.
    Rowlands MG; Bunnett MA; Foster AB; Jarman M; Stanek J; Schweizer E
    J Med Chem; 1988 May; 31(5):971-6. PubMed ID: 3361583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives.
    Laughton CA; McKenna R; Neidle S; Jarman M; McCague R; Rowlands MG
    J Med Chem; 1990 Sep; 33(9):2673-9. PubMed ID: 2391706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective aromatase inhibition by pyridoglutethimide, an analogue of aminoglutethimide.
    Kitawaki J; Yamamoto T; Urabe M; Tamura T; Inoue S; Honjo H; Okada H
    Acta Endocrinol (Copenh); 1990 May; 122(5):592-8. PubMed ID: 2353556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and pharmacokinetics of the N- and C-n-octyl analogues of pyridoglutethimide [3-ethyl-3-(4-pyridyl)piperidine-2,6-dione]: novel inhibitors of aromatase.
    Seago A; Baker MH; Houghton J; Leung CS; Jarman M
    Biochem Pharmacol; 1987 Feb; 36(4):573-7. PubMed ID: 3827945
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions.
    Nicholls PJ; Daly MJ; Smith HJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S55-67. PubMed ID: 3755630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and aromatase inhibition of 3-cycloalkyl-substituted 3-(4-aminophenyl)piperidine-2,6-diones.
    Hartmann RW; Batzl C; Pongratz TM; Mannschreck A
    J Med Chem; 1992 Jun; 35(12):2210-4. PubMed ID: 1613747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some 1-, and 3-substituted 3-(4'-aminophenyl)pyrrolidine-2,5-diones as selective inhibitors of aromatase.
    Whomsley R; Smith HJ; Nicholls PJ; Nazareth W; Ahmadi M
    J Enzyme Inhib; 1992; 6(4):317-30. PubMed ID: 1284968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
    Numazawa M; Yoshimura A; Oshibe M
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazole derivatives of pyrrolidonic and piperidonic as potential inhibitors of human placental aromatase in vitro.
    Baroudi M; Robert J; Luu-Duc C
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):73-7. PubMed ID: 8645619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological aromatization of delta4,6- and delta1,4,6-androgens and their 6-alkyl analogs, potent inhibitors of aromatase.
    Numazawa M; Yoshimura A
    J Steroid Biochem Mol Biol; 1999; 70(4-6):189-96. PubMed ID: 10622407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group.
    Numazawa M; Oshibe M; Yamaguchi S; Tachibana M
    J Med Chem; 1996 Mar; 39(5):1033-8. PubMed ID: 8676338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of 3-(prop-2-enyl)- and 3-(prop-2-ynyl)pyrrolidine-2,5-dione derivatives as potential aromatase inhibitors.
    Barrell KJ; Woo WL; Ahmadi M; Smith HJ; Nicholls PJ
    J Pharm Pharmacol; 1996 Feb; 48(2):154-9. PubMed ID: 8935164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione inhibitors as potential anti-tumour agents.
    Ahmed S; Smith JH; Nicholls PJ; Whomsley R; Cariuk P
    Drug Des Discov; 1995 Apr; 12(4):275-87. PubMed ID: 9040988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.